ATE408831T1 - Nachweisverfahren für delta-9- tetrahydrocannabinol - Google Patents

Nachweisverfahren für delta-9- tetrahydrocannabinol

Info

Publication number
ATE408831T1
ATE408831T1 AT05754731T AT05754731T ATE408831T1 AT E408831 T1 ATE408831 T1 AT E408831T1 AT 05754731 T AT05754731 T AT 05754731T AT 05754731 T AT05754731 T AT 05754731T AT E408831 T1 ATE408831 T1 AT E408831T1
Authority
AT
Austria
Prior art keywords
cannabis
testing
delta
employing
conjugate
Prior art date
Application number
AT05754731T
Other languages
English (en)
Inventor
Ahmed Jehanli
Christopher Hand
Original Assignee
Cozart Bioscience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cozart Bioscience Ltd filed Critical Cozart Bioscience Ltd
Application granted granted Critical
Publication of ATE408831T1 publication Critical patent/ATE408831T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5038Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving detection of metabolites per se
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G01N33/525Multi-layer analytical elements
    • G01N33/526Multi-layer analytical elements the element being adapted for a specific analyte
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/948Sedatives, e.g. cannabinoids, barbiturates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Anesthesiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Vending Machines For Individual Products (AREA)
  • Glass Compositions (AREA)
  • Tone Control, Compression And Expansion, Limiting Amplitude (AREA)
  • Reverberation, Karaoke And Other Acoustics (AREA)
AT05754731T 2004-07-02 2005-07-01 Nachweisverfahren für delta-9- tetrahydrocannabinol ATE408831T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0414898A GB2404023B (en) 2004-07-02 2004-07-02 Delta-9-tetrahydrocannabinol detection method

Publications (1)

Publication Number Publication Date
ATE408831T1 true ATE408831T1 (de) 2008-10-15

Family

ID=32843498

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05754731T ATE408831T1 (de) 2004-07-02 2005-07-01 Nachweisverfahren für delta-9- tetrahydrocannabinol

Country Status (9)

Country Link
US (1) US7790400B2 (de)
EP (1) EP1825262B1 (de)
CN (1) CN1981193B (de)
AT (1) ATE408831T1 (de)
AU (1) AU2005258886B2 (de)
DE (1) DE602005009863D1 (de)
ES (1) ES2311994T3 (de)
GB (1) GB2404023B (de)
WO (1) WO2006003472A1 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2404022B (en) 2004-06-14 2005-08-10 Cozart Bioscience Ltd Competitive assays for the detection of methamphetamine group drugs
GB2404023B (en) * 2004-07-02 2005-07-06 Cozart Bioscience Ltd Delta-9-tetrahydrocannabinol detection method
CN101495865B (zh) * 2005-05-20 2015-01-28 北京玛诺生物制药有限公司 口腔流体快速免疫层析检测
EP2027468B1 (de) * 2006-05-09 2011-06-22 Koninklijke Philips Electronics N.V. Nachweis von zielmolekülen in einer probe unter verwendung eines magnetfelds
CN101078715B (zh) * 2007-06-28 2010-12-08 艾博生物医药(杭州)有限公司 一种标准品溶液及其配制方法和应用
GB0725234D0 (en) * 2007-12-24 2008-02-06 Oxtex Ltd Electrochemical assays
KR101029306B1 (ko) 2010-07-23 2011-04-14 대한민국 대마 대사체 분석방법
US9709580B2 (en) * 2011-05-12 2017-07-18 William Marsh Rice University Bio-nano-chips for on-site drug screening
WO2013001102A1 (es) * 2011-06-27 2013-01-03 V.P. Pharma Baru, S.L. Sistema para la deteccion de drogas de abuso
US10408786B2 (en) 2012-06-14 2019-09-10 ChemiSensor, LLP Distributable chemical sampling and sensing system
US9423399B2 (en) 2012-09-28 2016-08-23 Takara Bio Usa, Inc. Lateral flow assays for tagged analytes
AU2014212313A1 (en) * 2013-01-30 2015-08-20 Thcer Llc Articles and methods for rapid THC detection
US9970950B1 (en) 2014-03-09 2018-05-15 Hound Labs, Inc. Method and apparatus for detecting acute use of target substance(s)
ES2989832T3 (es) 2014-03-18 2024-11-27 Izun Pharmaceuticals Corp Composiciones de cannabinoides unidos a proteínas
CA2850998A1 (en) * 2014-04-18 2015-10-18 Thc Breathalyzer, Inc. Cannabis drug detection device
GB2528657B (en) * 2014-07-24 2019-03-13 Intelligent Fingerprinting Ltd Sample analysing device
US10331275B2 (en) 2014-07-31 2019-06-25 Hewlett-Packard Development Company, L.P. Process image according to mat characteristic
US9726684B1 (en) 2015-01-18 2017-08-08 Hound Labs, Inc. Compositions for target substance detection and measurement
US10254298B1 (en) 2015-03-25 2019-04-09 National Technology & Engineering Solutions Of Sandia, Llc Detection of metabolites for controlled substances
EP3298159A4 (de) * 2015-05-20 2018-10-17 Agrivida, Inc. Verfahren zur steigerung der extraktion von enzymen aus tierfutter und messung der aktivität davon
US9817006B2 (en) * 2015-06-19 2017-11-14 Amy J. Reisinger Rapid and sensitive method of forensic toxicology in post-mortem subjects using oral fluid testing
US11726102B2 (en) 2015-07-24 2023-08-15 Washington State University Particle-based drug detection method and device embodiments
US20170023453A1 (en) * 2015-07-24 2017-01-26 Washington State University Particle-based drug detection methods
US9933445B1 (en) 2016-05-16 2018-04-03 Hound Labs, Inc. System and method for target substance identification
US10458963B2 (en) 2016-06-08 2019-10-29 Kathleen Stitzlein Quantitative HPTLC cannabinoid field testing device and method
US9921234B1 (en) 2016-06-17 2018-03-20 Hound Labs, Inc. Compositions and methods for detection of target constituent in exhaled breath
US10981174B1 (en) 2016-08-04 2021-04-20 National Technology & Engineering Solutions Of Sandia, Llc Protein and nucleic acid detection for microfluidic devices
CA3055692A1 (en) 2017-03-09 2018-09-13 Izun Pharmaceuticals Corp. Stabilized protein-bound cannabinoid compositions
WO2018200794A1 (en) 2017-04-28 2018-11-01 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Tetrahydrocannabinol sensor
US11026596B1 (en) 2017-05-19 2021-06-08 Hound Labs, Inc. Detection and measurement of target substance in exhaled breath
CA3070455A1 (en) 2017-07-19 2019-01-24 Evanostics, Llc Cartridges for oral fluid analysis and methods of use
US11187711B1 (en) 2017-09-11 2021-11-30 Hound Labs, Inc. Analyte detection from breath samples
WO2019118989A1 (en) 2017-12-15 2019-06-20 Evanostics Llc Optical reader for analyte testing
US11426097B1 (en) 2018-10-17 2022-08-30 Hound Labs, Inc. Rotary valve assemblies and methods of use for breath sample cartridge systems
WO2020132146A1 (en) 2018-12-18 2020-06-25 Evanostics Llc Optical analyte detection
US20200245899A1 (en) 2019-01-31 2020-08-06 Hound Labs, Inc. Mechanical Breath Collection Device
WO2020167828A1 (en) 2019-02-11 2020-08-20 Giner, Inc. Method and system for detection and/or quantification of delta-9-tetrahydrocannabinol in exhaled breath
US11977086B2 (en) 2019-03-21 2024-05-07 Hound Labs, Inc. Biomarker detection from breath samples
US12019002B2 (en) * 2019-07-03 2024-06-25 Pinpoint Testing, Llc Ready-to-extract platforms for chemical analysis and quantification of unknown samples using spiked matrix standards
US11493451B2 (en) * 2019-12-23 2022-11-08 Palo Alto Research Center Incorporated Colorimetric drug test strip using porous support material
US11933731B1 (en) 2020-05-13 2024-03-19 Hound Labs, Inc. Systems and methods using Surface-Enhanced Raman Spectroscopy for detecting tetrahydrocannabinol
US12392769B1 (en) 2021-01-12 2025-08-19 Hound Labs, Inc. Ambient contamination in breath analyte detection and measurement
CN119534358A (zh) * 2023-08-28 2025-02-28 广州达安基因股份有限公司 Δ9-四氢大麻酚的检测试剂及其制备方法和检测方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4067774A (en) 1971-05-14 1978-01-10 Syva Company Compounds for enzyme amplification assay
US5677132A (en) * 1971-05-20 1997-10-14 Strahilevitz; Meir Immunological assay reagent package
US3996344A (en) 1972-05-15 1976-12-07 Biological Developments, Inc. Phenethylamine antigenic conjugates, their preparation, antibodies and use
US4041076A (en) 1974-10-23 1977-08-09 Hoffmann-La Roche Inc. Immunoassay for pharmacologically active phenethylamines
US4016146A (en) 1974-12-10 1977-04-05 Biological Developments, Inc. Phenethylamine antigenic conjugates, their preparation, antibodies, and use
US4329281A (en) 1978-06-05 1982-05-11 Hoffmann-La Roche Inc. Hapten compositions
US4771005A (en) * 1983-06-27 1988-09-13 Erez Forensic Technology Ltd. Reagents, test kits and methods for the detection of cannabinoids
US5223441A (en) * 1986-10-09 1993-06-29 Syntex (U.S.A.) Inc. Receptors for immune complexes
US4868132A (en) 1987-02-03 1989-09-19 Abbott Laboratories Fluorescence polarization immunoassay for amphetamine/methamphetamine
US5144030A (en) * 1987-02-17 1992-09-01 Abbott Laboratories Fluorescene polarization immunoassay for tetrahydrocannabinoids
ATE195022T1 (de) 1987-04-27 2000-08-15 Unilever Nv Spezifische bindungstestverfahren
US4843020A (en) 1988-01-14 1989-06-27 Woodford W James Method for detecting tetrahydrocannabinol in human urine involving melanin precipitation
US5026827A (en) 1988-09-02 1991-06-25 Matsushita Electric Industrial Co., Ltd. Amphetamine-protein complex as immunogen for obtaining antibodies specific to methamphetamine
DE68924243T2 (de) 1988-10-28 1996-03-28 Abbott Lab Verfahren und Reagenzien zum Nachweis von Amphetamin und/oder d-Methamphetamin in biologischen Proben.
US5248791A (en) 1989-04-10 1993-09-28 Abbott Laboratories Reagents, methods and kits for an amphetamine-class fluorescence polarization immunoassay
US5238652A (en) * 1990-06-20 1993-08-24 Drug Screening Systems, Inc. Analytical test devices for competition assay for drugs of non-protein antigens using immunochromatographic techniques
US5279955A (en) * 1991-03-01 1994-01-18 Pegg Randall K Heterofunctional crosslinking agent for immobilizing reagents on plastic substrates
US5237057A (en) * 1992-04-06 1993-08-17 Biosite Diagnostics, Inc. Tetrahydrocannabinol derivatives and protein and polypeptide tetrahydrocannabinol derivative conjugates and labels
KR0155608B1 (ko) 1995-07-14 1998-12-01 박홍기 원적외선 방사성 폴리에스테르 섬유의 제조방법
GB2339615B (en) 1998-07-14 2001-02-07 Cozart Bioscience Ltd Screening device and method of screening an immunoassay test
NZ513452A (en) * 1999-03-22 2004-03-26 Pfizer Resorcinol derivatives
GB2361473C (en) 2000-03-08 2005-06-28 Microgenics Corp Ecstasy-class analogs and use of same in detection of ecstasy-class compounds
US6534325B1 (en) 2000-06-30 2003-03-18 Roche Diagnostics Corporation Immunoassay for the detection of amphetamines, methamphetamines and methylenedioxy designer amphetamines
SE0002820L (sv) * 2000-08-04 2002-02-05 Jordanian Pharmaceutical Mfg & Medicinskt kit
US6472228B2 (en) 2000-12-04 2002-10-29 Lifepoint, Inc. Composition and methods for synthesis of novel tracers for detecting amphetamine and methamphetamine in samples
US7169907B2 (en) 2002-03-01 2007-01-30 Roche Diagnostics Operations, Inc. Derivatives, immunogens, and antibodies for detecting ecstasy-class drugs
GB0405999D0 (en) 2004-03-17 2004-04-21 Cozart Bioscience Ltd Procedure for manufacture of strips for lateral flow immunochromatographic devices
GB2404022B (en) 2004-06-14 2005-08-10 Cozart Bioscience Ltd Competitive assays for the detection of methamphetamine group drugs
GB2404023B (en) 2004-07-02 2005-07-06 Cozart Bioscience Ltd Delta-9-tetrahydrocannabinol detection method

Also Published As

Publication number Publication date
GB2404023A (en) 2005-01-19
AU2005258886A1 (en) 2006-01-12
GB2404023B (en) 2005-07-06
US7790400B2 (en) 2010-09-07
GB0414898D0 (en) 2004-08-04
EP1825262A1 (de) 2007-08-29
EP1825262B1 (de) 2008-09-17
ES2311994T3 (es) 2009-02-16
AU2005258886B2 (en) 2007-10-11
US20090017555A1 (en) 2009-01-15
HK1102308A1 (en) 2007-11-16
GB2404023A8 (en) 2005-01-20
WO2006003472A1 (en) 2006-01-12
CN1981193B (zh) 2012-02-01
DE602005009863D1 (de) 2008-10-30
CN1981193A (zh) 2007-06-13

Similar Documents

Publication Publication Date Title
ATE408831T1 (de) Nachweisverfahren für delta-9- tetrahydrocannabinol
RU2008136193A (ru) Детектирование рака по повышенным уровням bcl-2
WO2009058902A3 (en) Methods and devices for analyte detection
DK1322956T3 (da) Fremgangsmåde til diagnose af immunologisk födevarefölsomhed
EA200500356A1 (ru) Способы обнаружения амниотической жидкости во влагалищном секрете и устройства для реализации указанных способов
WO2009094058A3 (en) Real-time, single-step bioassay using nanoplasmonic resonator with ultra-high sensitivity
CA2863353C (en) Devices, methods, and test kits for electronic analyte assaying
WO2006089027A3 (en) Lateral flow test kit and method for detecting an analyte
ATE423972T1 (de) Vorrichtung und verfahren um gleichzeitig verschiedene antikörper und antigene nachzuweisen in klinischen, nahrungsmittel- und umwelt-proben
MX2010013692A (es) Deteccion de uso de cannabis.
DE60237395D1 (de) Internes kalibriersystem für durchflusstests
WO2008030546A3 (en) Lateral flow test strip with migrating label
DE602004031253D1 (de) Flüssigprobenanalysevorrichtung mit verschliessbarem probenaufbewahrungsreservoir
WO2005093414A3 (en) Assay devices utilizing chemichromic dyes
BRPI0408255A (pt) sistema de processamento de sinal e método
RU2013118695A (ru) Устройства, способы и наборы для иммунохроматографии
EP1494030A3 (de) Lösung zur Vorbehandlung eines Grippevirentests basierend auf Immunchromatographie
WO2006069023A3 (en) Assay method and apparatus with reduced sample matrix effects
BRPI0518812A2 (pt) dispositivo de teste de fluxo lateral proporcionado validade de resultado de teste aperfeiÇoada
BRPI0515223A (pt) dispositivo integrado para análises diagnósticas e método relativo
WO2011138592A3 (en) Devices and mehtods for testing analytes
UA96597C2 (ru) Устройство и способ определения гормона, ассоциированного с беременностью
ATE369564T1 (de) Differenzielles immunoassay für myoglobin
DK1275963T3 (da) Testapparat med volumenmåler
BRPI0519011A2 (pt) marcador para leituras feitas em testes em locais alternativos

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties
REN Ceased due to non-payment of the annual fee